A large and apprently artificial collection of diverse kinetoplastid protein kinases. None of them appear to be TM.
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 2 |
| Forrest at al. (procyclic) | no | yes: 2 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 12 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 19 |
| NetGPI | no | yes: 0, no: 19 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0005930 | axoneme | 2 | 2 |
| GO:0005952 | cAMP-dependent protein kinase complex | 3 | 2 |
| GO:0031974 | membrane-enclosed lumen | 2 | 2 |
| GO:0031981 | nuclear lumen | 5 | 2 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
| GO:0032991 | protein-containing complex | 1 | 2 |
| GO:0043233 | organelle lumen | 3 | 2 |
| GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 2 |
| GO:0070013 | intracellular organelle lumen | 4 | 2 |
| GO:0097014 | ciliary plasm | 5 | 2 |
| GO:0099568 | cytoplasmic region | 3 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0140535 | intracellular protein-containing complex | 2 | 2 |
| GO:1902494 | catalytic complex | 2 | 2 |
| GO:1902554 | serine/threonine protein kinase complex | 6 | 2 |
| GO:1902911 | protein kinase complex | 5 | 2 |
| GO:1990234 | transferase complex | 3 | 2 |
Related structures:
AlphaFold database: E9B0K7
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006468 | protein phosphorylation | 5 | 20 |
| GO:0006793 | phosphorus metabolic process | 3 | 20 |
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 20 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 20 |
| GO:0008152 | metabolic process | 1 | 20 |
| GO:0009987 | cellular process | 1 | 20 |
| GO:0016310 | phosphorylation | 5 | 20 |
| GO:0019538 | protein metabolic process | 3 | 20 |
| GO:0036211 | protein modification process | 4 | 20 |
| GO:0043170 | macromolecule metabolic process | 3 | 20 |
| GO:0043412 | macromolecule modification | 4 | 20 |
| GO:0044237 | cellular metabolic process | 2 | 20 |
| GO:0044238 | primary metabolic process | 2 | 20 |
| GO:0071704 | organic substance metabolic process | 2 | 20 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 20 |
| GO:0007165 | signal transduction | 2 | 3 |
| GO:0018105 | peptidyl-serine phosphorylation | 6 | 3 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
| GO:0018209 | peptidyl-serine modification | 6 | 3 |
| GO:0050789 | regulation of biological process | 2 | 3 |
| GO:0050794 | regulation of cellular process | 3 | 3 |
| GO:0065007 | biological regulation | 1 | 3 |
| GO:0035556 | intracellular signal transduction | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 20 |
| GO:0003824 | catalytic activity | 1 | 20 |
| GO:0004672 | protein kinase activity | 3 | 20 |
| GO:0004674 | protein serine/threonine kinase activity | 4 | 20 |
| GO:0005488 | binding | 1 | 20 |
| GO:0005524 | ATP binding | 5 | 20 |
| GO:0016301 | kinase activity | 4 | 20 |
| GO:0016740 | transferase activity | 2 | 20 |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 20 |
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 20 |
| GO:0017076 | purine nucleotide binding | 4 | 20 |
| GO:0030554 | adenyl nucleotide binding | 5 | 20 |
| GO:0032553 | ribonucleotide binding | 3 | 20 |
| GO:0032555 | purine ribonucleotide binding | 4 | 20 |
| GO:0032559 | adenyl ribonucleotide binding | 5 | 20 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 20 |
| GO:0036094 | small molecule binding | 2 | 20 |
| GO:0043167 | ion binding | 2 | 20 |
| GO:0043168 | anion binding | 3 | 20 |
| GO:0097159 | organic cyclic compound binding | 2 | 20 |
| GO:0097367 | carbohydrate derivative binding | 2 | 20 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 20 |
| GO:1901265 | nucleoside phosphate binding | 3 | 20 |
| GO:1901363 | heterocyclic compound binding | 2 | 20 |
| GO:0004690 | cyclic nucleotide-dependent protein kinase activity | 5 | 2 |
| GO:0004691 | cAMP-dependent protein kinase activity | 6 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.353 |
| CLV_NRD_NRD_1 | 369 | 371 | PF00675 | 0.403 |
| CLV_NRD_NRD_1 | 437 | 439 | PF00675 | 0.597 |
| CLV_NRD_NRD_1 | 495 | 497 | PF00675 | 0.721 |
| CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.630 |
| CLV_PCSK_FUR_1 | 435 | 439 | PF00082 | 0.599 |
| CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.434 |
| CLV_PCSK_KEX2_1 | 437 | 439 | PF00082 | 0.597 |
| CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.537 |
| CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.366 |
| CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.375 |
| CLV_PCSK_SKI1_1 | 313 | 317 | PF00082 | 0.450 |
| CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.384 |
| CLV_PCSK_SKI1_1 | 370 | 374 | PF00082 | 0.411 |
| CLV_PCSK_SKI1_1 | 388 | 392 | PF00082 | 0.489 |
| CLV_PCSK_SKI1_1 | 442 | 446 | PF00082 | 0.519 |
| CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.464 |
| CLV_PCSK_SKI1_1 | 497 | 501 | PF00082 | 0.588 |
| DEG_APCC_DBOX_1 | 153 | 161 | PF00400 | 0.361 |
| DOC_CKS1_1 | 375 | 380 | PF01111 | 0.589 |
| DOC_CYCLIN_RxL_1 | 40 | 51 | PF00134 | 0.573 |
| DOC_CYCLIN_yClb1_LxF_4 | 297 | 303 | PF00134 | 0.450 |
| DOC_CYCLIN_yCln2_LP_2 | 372 | 378 | PF00134 | 0.447 |
| DOC_MAPK_gen_1 | 227 | 236 | PF00069 | 0.433 |
| DOC_MAPK_gen_1 | 354 | 364 | PF00069 | 0.590 |
| DOC_PP1_RVXF_1 | 279 | 286 | PF00149 | 0.375 |
| DOC_PP2B_LxvP_1 | 372 | 375 | PF13499 | 0.447 |
| DOC_PP2B_PxIxI_1 | 322 | 328 | PF00149 | 0.299 |
| DOC_PP4_FxxP_1 | 505 | 508 | PF00568 | 0.620 |
| DOC_USP7_UBL2_3 | 126 | 130 | PF12436 | 0.363 |
| DOC_USP7_UBL2_3 | 503 | 507 | PF12436 | 0.614 |
| DOC_WW_Pin1_4 | 374 | 379 | PF00397 | 0.579 |
| DOC_WW_Pin1_4 | 397 | 402 | PF00397 | 0.703 |
| DOC_WW_Pin1_4 | 420 | 425 | PF00397 | 0.752 |
| DOC_WW_Pin1_4 | 450 | 455 | PF00397 | 0.781 |
| DOC_WW_Pin1_4 | 462 | 467 | PF00397 | 0.853 |
| DOC_WW_Pin1_4 | 488 | 493 | PF00397 | 0.657 |
| DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.402 |
| LIG_14-3-3_CanoR_1 | 345 | 351 | PF00244 | 0.450 |
| LIG_14-3-3_CanoR_1 | 80 | 88 | PF00244 | 0.599 |
| LIG_Actin_WH2_2 | 38 | 55 | PF00022 | 0.579 |
| LIG_APCC_ABBAyCdc20_2 | 222 | 228 | PF00400 | 0.396 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.434 |
| LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.400 |
| LIG_EH1_1 | 178 | 186 | PF00400 | 0.431 |
| LIG_eIF4E_1 | 179 | 185 | PF01652 | 0.450 |
| LIG_eIF4E_1 | 268 | 274 | PF01652 | 0.450 |
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.398 |
| LIG_FHA_1 | 314 | 320 | PF00498 | 0.394 |
| LIG_FHA_1 | 329 | 335 | PF00498 | 0.426 |
| LIG_FHA_1 | 389 | 395 | PF00498 | 0.608 |
| LIG_FHA_1 | 58 | 64 | PF00498 | 0.527 |
| LIG_FHA_2 | 190 | 196 | PF00498 | 0.450 |
| LIG_FHA_2 | 29 | 35 | PF00498 | 0.446 |
| LIG_FHA_2 | 427 | 433 | PF00498 | 0.802 |
| LIG_FHA_2 | 49 | 55 | PF00498 | 0.328 |
| LIG_FHA_2 | 94 | 100 | PF00498 | 0.433 |
| LIG_LIR_Apic_2 | 265 | 271 | PF02991 | 0.375 |
| LIG_LIR_Apic_2 | 504 | 508 | PF02991 | 0.617 |
| LIG_LIR_Gen_1 | 15 | 26 | PF02991 | 0.523 |
| LIG_LIR_Gen_1 | 189 | 199 | PF02991 | 0.496 |
| LIG_LIR_Gen_1 | 2 | 10 | PF02991 | 0.541 |
| LIG_LIR_Gen_1 | 294 | 303 | PF02991 | 0.382 |
| LIG_LIR_Nem_3 | 116 | 120 | PF02991 | 0.398 |
| LIG_LIR_Nem_3 | 15 | 21 | PF02991 | 0.362 |
| LIG_LIR_Nem_3 | 189 | 194 | PF02991 | 0.375 |
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.420 |
| LIG_LIR_Nem_3 | 284 | 288 | PF02991 | 0.303 |
| LIG_LIR_Nem_3 | 294 | 300 | PF02991 | 0.370 |
| LIG_LIR_Nem_3 | 363 | 367 | PF02991 | 0.440 |
| LIG_MLH1_MIPbox_1 | 69 | 73 | PF16413 | 0.327 |
| LIG_Pex14_1 | 14 | 18 | PF04695 | 0.525 |
| LIG_Pex14_2 | 106 | 110 | PF04695 | 0.400 |
| LIG_Pex14_2 | 386 | 390 | PF04695 | 0.458 |
| LIG_PTB_Apo_2 | 358 | 365 | PF02174 | 0.484 |
| LIG_SH2_CRK | 117 | 121 | PF00017 | 0.450 |
| LIG_SH2_PTP2 | 18 | 21 | PF00017 | 0.375 |
| LIG_SH2_SRC | 18 | 21 | PF00017 | 0.375 |
| LIG_SH2_SRC | 218 | 221 | PF00017 | 0.391 |
| LIG_SH2_STAP1 | 208 | 212 | PF00017 | 0.396 |
| LIG_SH2_STAP1 | 413 | 417 | PF00017 | 0.449 |
| LIG_SH2_STAT3 | 170 | 173 | PF00017 | 0.318 |
| LIG_SH2_STAT3 | 193 | 196 | PF00017 | 0.331 |
| LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.313 |
| LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.406 |
| LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.433 |
| LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.384 |
| LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.368 |
| LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.391 |
| LIG_SH2_STAT5 | 411 | 414 | PF00017 | 0.587 |
| LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.428 |
| LIG_SH3_3 | 251 | 257 | PF00018 | 0.519 |
| LIG_SH3_3 | 316 | 322 | PF00018 | 0.450 |
| LIG_SH3_3 | 372 | 378 | PF00018 | 0.480 |
| LIG_SH3_3 | 4 | 10 | PF00018 | 0.391 |
| LIG_SH3_3 | 52 | 58 | PF00018 | 0.555 |
| LIG_TRAF2_1 | 171 | 174 | PF00917 | 0.450 |
| LIG_TRAF2_1 | 418 | 421 | PF00917 | 0.568 |
| LIG_TYR_ITIM | 224 | 229 | PF00017 | 0.410 |
| LIG_TYR_ITSM | 14 | 21 | PF00017 | 0.513 |
| LIG_UBA3_1 | 334 | 341 | PF00899 | 0.450 |
| MOD_CDK_SPxxK_3 | 6 | 13 | PF00069 | 0.408 |
| MOD_CK1_1 | 440 | 446 | PF00069 | 0.651 |
| MOD_CK1_1 | 453 | 459 | PF00069 | 0.819 |
| MOD_CK1_1 | 488 | 494 | PF00069 | 0.562 |
| MOD_CK1_1 | 93 | 99 | PF00069 | 0.664 |
| MOD_CK2_1 | 168 | 174 | PF00069 | 0.396 |
| MOD_CK2_1 | 189 | 195 | PF00069 | 0.358 |
| MOD_CK2_1 | 397 | 403 | PF00069 | 0.545 |
| MOD_CK2_1 | 415 | 421 | PF00069 | 0.671 |
| MOD_CK2_1 | 426 | 432 | PF00069 | 0.791 |
| MOD_CK2_1 | 48 | 54 | PF00069 | 0.531 |
| MOD_CK2_1 | 93 | 99 | PF00069 | 0.622 |
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.414 |
| MOD_GlcNHglycan | 136 | 140 | PF01048 | 0.394 |
| MOD_GlcNHglycan | 36 | 40 | PF01048 | 0.615 |
| MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.568 |
| MOD_GSK3_1 | 258 | 265 | PF00069 | 0.377 |
| MOD_GSK3_1 | 420 | 427 | PF00069 | 0.724 |
| MOD_GSK3_1 | 445 | 452 | PF00069 | 0.708 |
| MOD_GSK3_1 | 458 | 465 | PF00069 | 0.767 |
| MOD_GSK3_1 | 497 | 504 | PF00069 | 0.726 |
| MOD_GSK3_1 | 53 | 60 | PF00069 | 0.590 |
| MOD_GSK3_1 | 95 | 102 | PF00069 | 0.545 |
| MOD_N-GLC_1 | 397 | 402 | PF02516 | 0.759 |
| MOD_N-GLC_1 | 445 | 450 | PF02516 | 0.798 |
| MOD_N-GLC_1 | 458 | 463 | PF02516 | 0.840 |
| MOD_N-GLC_1 | 501 | 506 | PF02516 | 0.636 |
| MOD_NEK2_1 | 168 | 173 | PF00069 | 0.387 |
| MOD_NEK2_2 | 84 | 89 | PF00069 | 0.485 |
| MOD_PKA_1 | 125 | 131 | PF00069 | 0.461 |
| MOD_PKA_1 | 437 | 443 | PF00069 | 0.741 |
| MOD_PKA_1 | 497 | 503 | PF00069 | 0.602 |
| MOD_PKA_2 | 437 | 443 | PF00069 | 0.771 |
| MOD_PKA_2 | 79 | 85 | PF00069 | 0.445 |
| MOD_PKB_1 | 435 | 443 | PF00069 | 0.607 |
| MOD_Plk_1 | 501 | 507 | PF00069 | 0.637 |
| MOD_Plk_1 | 68 | 74 | PF00069 | 0.452 |
| MOD_Plk_2-3 | 189 | 195 | PF00069 | 0.410 |
| MOD_Plk_2-3 | 99 | 105 | PF00069 | 0.462 |
| MOD_Plk_4 | 68 | 74 | PF00069 | 0.499 |
| MOD_ProDKin_1 | 374 | 380 | PF00069 | 0.591 |
| MOD_ProDKin_1 | 397 | 403 | PF00069 | 0.710 |
| MOD_ProDKin_1 | 420 | 426 | PF00069 | 0.757 |
| MOD_ProDKin_1 | 450 | 456 | PF00069 | 0.784 |
| MOD_ProDKin_1 | 462 | 468 | PF00069 | 0.853 |
| MOD_ProDKin_1 | 488 | 494 | PF00069 | 0.655 |
| MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.406 |
| MOD_SUMO_for_1 | 229 | 232 | PF00179 | 0.375 |
| MOD_SUMO_rev_2 | 105 | 111 | PF00179 | 0.501 |
| MOD_SUMO_rev_2 | 140 | 150 | PF00179 | 0.450 |
| MOD_SUMO_rev_2 | 20 | 26 | PF00179 | 0.520 |
| MOD_SUMO_rev_2 | 329 | 334 | PF00179 | 0.499 |
| MOD_SUMO_rev_2 | 44 | 50 | PF00179 | 0.562 |
| MOD_SUMO_rev_2 | 76 | 82 | PF00179 | 0.562 |
| TRG_DiLeu_BaEn_1 | 330 | 335 | PF01217 | 0.396 |
| TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.471 |
| TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.387 |
| TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.277 |
| TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.410 |
| TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.448 |
| TRG_ER_diArg_1 | 345 | 347 | PF00400 | 0.360 |
| TRG_ER_diArg_1 | 434 | 437 | PF00400 | 0.597 |
| TRG_NLS_Bipartite_1 | 480 | 500 | PF00514 | 0.592 |
| TRG_Pf-PMV_PEXEL_1 | 154 | 158 | PF00026 | 0.361 |
| TRG_Pf-PMV_PEXEL_1 | 227 | 232 | PF00026 | 0.375 |
| TRG_Pf-PMV_PEXEL_1 | 313 | 317 | PF00026 | 0.450 |
| TRG_Pf-PMV_PEXEL_1 | 415 | 419 | PF00026 | 0.478 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P4J7 | Leptomonas seymouri | 29% | 100% |
| A0A0N1I191 | Leptomonas seymouri | 26% | 69% |
| A0A0S4J4B3 | Bodo saltans | 27% | 100% |
| A0A0S4JCG2 | Bodo saltans | 30% | 100% |
| A0A0S4JER5 | Bodo saltans | 43% | 100% |
| A0A0S4JI67 | Bodo saltans | 30% | 100% |
| A0A0S4JNA1 | Bodo saltans | 25% | 100% |
| A0A1X0P3J5 | Trypanosomatidae | 40% | 100% |
| A0A3Q8IC87 | Leishmania donovani | 29% | 100% |
| A0A3Q8IIG1 | Leishmania donovani | 25% | 100% |
| A0A3Q8INQ4 | Leishmania donovani | 35% | 100% |
| A0A3Q8IRT6 | Leishmania donovani | 97% | 100% |
| A0A3Q8IVR8 | Leishmania donovani | 24% | 100% |
| A0A3R7RLL1 | Trypanosoma rangeli | 29% | 100% |
| A0A3S5H5U5 | Leishmania donovani | 28% | 100% |
| A0A3S7WTN9 | Leishmania donovani | 31% | 100% |
| A0A3S7WWE7 | Leishmania donovani | 25% | 100% |
| A0A3S7X7Y2 | Leishmania donovani | 25% | 100% |
| A0A3S7X9R4 | Leishmania donovani | 41% | 100% |
| A0A3S7X9S2 | Leishmania donovani | 41% | 100% |
| A0A422NZ62 | Trypanosoma rangeli | 37% | 74% |
| A0A422P4V9 | Trypanosoma rangeli | 40% | 100% |
| A4H4S9 | Leishmania braziliensis | 28% | 100% |
| A4H8C4 | Leishmania braziliensis | 30% | 100% |
| A4HAS1 | Leishmania braziliensis | 26% | 100% |
| A4HBL4 | Leishmania braziliensis | 26% | 100% |
| A4HCD7 | Leishmania braziliensis | 30% | 100% |
| A4HCE6 | Leishmania braziliensis | 28% | 100% |
| A4HED7 | Leishmania braziliensis | 34% | 100% |
| A4HFF3 | Leishmania braziliensis | 26% | 100% |
| A4HI35 | Leishmania braziliensis | 91% | 100% |
| A4HLR0 | Leishmania braziliensis | 28% | 100% |
| A4HN71 | Leishmania braziliensis | 41% | 100% |
| A4HNT2 | Leishmania braziliensis | 23% | 100% |
| A4HWP5 | Leishmania infantum | 31% | 100% |
| A4HZA2 | Leishmania infantum | 25% | 100% |
| A4HZV1 | Leishmania infantum | 29% | 100% |
| A4I1T4 | Leishmania infantum | 35% | 100% |
| A4I435 | Leishmania infantum | 25% | 100% |
| A4I5B1 | Leishmania infantum | 96% | 100% |
| A4I9Y5 | Leishmania infantum | 25% | 100% |
| A4IBT4 | Leishmania infantum | 41% | 100% |
| A4IBT9 | Leishmania infantum | 41% | 100% |
| A4ICR2 | Leishmania infantum | 24% | 100% |
| C6K3W8 | Leptomonas seymouri | 72% | 97% |
| C9ZKX6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 100% |
| C9ZQP5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
| C9ZTP2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
| E8NHS0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
| E9AET0 | Leishmania major | 24% | 100% |
| E9AFM1 | Leishmania major | 41% | 100% |
| E9AG71 | Leishmania infantum | 28% | 100% |
| E9AKZ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
| E9AQF3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
| E9AUY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
| E9AVR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
| E9AVS7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
| E9AXW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
| E9B0C2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
| E9B436 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
| E9B4Z4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
| E9B6S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
| E9B6S9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
| P05130 | Drosophila melanogaster | 34% | 75% |
| P16054 | Mus musculus | 32% | 69% |
| P18652 | Gallus gallus | 39% | 68% |
| P18654 | Mus musculus | 39% | 69% |
| P18961 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 38% | 75% |
| P23443 | Homo sapiens | 38% | 97% |
| P28867 | Mus musculus | 33% | 76% |
| P31748 | AKT8 murine leukemia virus | 36% | 100% |
| P31749 | Homo sapiens | 35% | 100% |
| P31750 | Mus musculus | 36% | 100% |
| P34885 | Caenorhabditis elegans | 35% | 72% |
| P38070 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 34% | 97% |
| P47196 | Rattus norvegicus | 36% | 100% |
| P51812 | Homo sapiens | 39% | 69% |
| P53894 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 67% |
| P54265 | Mus musculus | 29% | 81% |
| P54644 | Dictyostelium discoideum | 37% | 100% |
| P67998 | Oryctolagus cuniculus | 38% | 97% |
| P67999 | Rattus norvegicus | 38% | 97% |
| Q01314 | Bos taurus | 35% | 100% |
| Q09831 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 90% |
| Q09898 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 84% |
| Q39030 | Arabidopsis thaliana | 38% | 100% |
| Q4Q0B0 | Leishmania major | 26% | 100% |
| Q4Q204 | Leishmania major | 23% | 100% |
| Q4Q2Z2 | Leishmania major | 25% | 100% |
| Q4Q7M5 | Leishmania major | 96% | 100% |
| Q4Q7W2 | Leishmania major | 27% | 100% |
| Q4Q9K2 | Leishmania major | 34% | 100% |
| Q4QBQ2 | Leishmania major | 28% | 100% |
| Q4QBR6 | Leishmania major | 30% | 98% |
| Q4QCK0 | Leishmania major | 25% | 100% |
| Q4QF23 | Leishmania major | 33% | 100% |
| Q4QIV8 | Leishmania major | 28% | 100% |
| Q4R633 | Macaca fascicularis | 39% | 100% |
| Q54IH8 | Dictyostelium discoideum | 28% | 94% |
| Q5AP53 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 30% | 70% |
| Q5Q0U5 | Fundulus heteroclitus | 39% | 100% |
| Q5R7A7 | Pongo abelii | 37% | 100% |
| Q6BLJ9 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 31% | 71% |
| Q6CFS5 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 31% | 87% |
| Q6TGC6 | Pneumocystis carinii | 32% | 100% |
| Q6TJY3 | Bos taurus | 38% | 97% |
| Q7LZQ8 | Xenopus laevis | 33% | 76% |
| Q8BSK8 | Mus musculus | 38% | 97% |
| Q8R4V0 | Rattus norvegicus | 38% | 100% |
| Q90XF2 | Danio rerio | 36% | 87% |
| Q96BR1 | Homo sapiens | 37% | 100% |
| Q98TY9 | Xenopus laevis | 34% | 100% |
| Q9ERE3 | Mus musculus | 38% | 100% |
| Q9GNR4 | Leishmania major | 41% | 100% |
| Q9UBS0 | Homo sapiens | 40% | 100% |
| Q9UK32 | Homo sapiens | 25% | 68% |
| Q9WUT3 | Mus musculus | 39% | 70% |
| Q9Z1M4 | Mus musculus | 39% | 100% |
| V5BCH2 | Trypanosoma cruzi | 34% | 100% |
| V5DQT5 | Trypanosoma cruzi | 41% | 100% |